GB1579241A - Compositions for treating hypercholes-terolemia - Google Patents

Compositions for treating hypercholes-terolemia Download PDF

Info

Publication number
GB1579241A
GB1579241A GB5716/77A GB571677A GB1579241A GB 1579241 A GB1579241 A GB 1579241A GB 5716/77 A GB5716/77 A GB 5716/77A GB 571677 A GB571677 A GB 571677A GB 1579241 A GB1579241 A GB 1579241A
Authority
GB
United Kingdom
Prior art keywords
vitamin
composition
composition according
fatty acid
anal leakage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5716/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/657,528 external-priority patent/US4005195A/en
Priority claimed from US05/657,529 external-priority patent/US4005196A/en
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of GB1579241A publication Critical patent/GB1579241A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicinal Preparation (AREA)
GB5716/77A 1976-02-12 1977-02-11 Compositions for treating hypercholes-terolemia Expired GB1579241A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/657,528 US4005195A (en) 1976-02-12 1976-02-12 Compositions for treating hypercholesterolemia
US05/657,529 US4005196A (en) 1976-02-12 1976-02-12 Vitaminized compositions for treating hypercholesterolemia

Publications (1)

Publication Number Publication Date
GB1579241A true GB1579241A (en) 1980-11-19

Family

ID=27097425

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5716/77A Expired GB1579241A (en) 1976-02-12 1977-02-11 Compositions for treating hypercholes-terolemia

Country Status (8)

Country Link
JP (1) JPS52120131A (xx)
DE (1) DE2705105A1 (xx)
FR (1) FR2340737A1 (xx)
GB (1) GB1579241A (xx)
IE (1) IE44458B1 (xx)
IT (1) IT1075126B (xx)
LU (1) LU76751A1 (xx)
NL (1) NL188503C (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368213A (en) * 1981-06-23 1983-01-11 The Procter & Gamble Company Emulsion concentrate for palatable polyester beverage
EP0233856B1 (en) * 1986-02-20 1994-01-05 The Procter & Gamble Company Better tasting low calorie fat materials
DE3788443T2 (de) * 1986-02-20 1994-04-28 Procter & Gamble Kalorienarme Fettprodukte, die die laxierenden Nebeneffekte ausschliessen.
US4849222A (en) * 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
JPH07108184B2 (ja) * 1987-11-25 1995-11-22 三菱化学株式会社 チヨコレートの製造法
US5006360B1 (en) * 1988-06-27 1992-04-28 Low calorie fat substitute compositions resistant to laxative side effect
CA2004723C (en) * 1988-12-22 1997-03-04 James Anthony Letton Fatty compositions with high solids content

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997492A (en) * 1959-02-17 1961-08-22 Procter & Gamble Method for preparing fatty esters of straight chain hexitols
US2997491A (en) * 1959-09-29 1961-08-22 Procter & Gamble Method for preparing partial fatty esters of inositol
US3059009A (en) * 1961-09-21 1962-10-16 Proeter & Gamble Company Fat crystallization process
US3158490A (en) * 1962-03-27 1964-11-24 Procter & Gamble Salad oils and method of making them
US3600186A (en) * 1968-04-23 1971-08-17 Procter & Gamble Low calorie fat-containing food compositions
US3809711A (en) * 1972-04-07 1974-05-07 Procter & Gamble Process for synthesizing specific complete mixed polyol esters
US3954976A (en) * 1973-12-14 1976-05-04 The Procter & Gamble Company Pharmaceutical compositions for inhibiting absorption of cholesterol
US3963699A (en) * 1974-01-10 1976-06-15 The Procter & Gamble Company Synthesis of higher polyol fatty acid polyesters
US4034083A (en) * 1975-11-03 1977-07-05 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
EP0236288B1 (en) * 1986-02-20 1993-12-15 The Procter & Gamble Company Low calorie fat materials that eliminate laxative side effect

Also Published As

Publication number Publication date
IE44458L (en) 1977-08-12
NL188503C (nl) 1995-05-16
IT1075126B (it) 1985-04-22
DE2705105C2 (xx) 1987-06-11
JPS52120131A (en) 1977-10-08
IE44458B1 (en) 1981-12-02
LU76751A1 (xx) 1977-08-19
FR2340737A1 (fr) 1977-09-09
NL188503B (nl) 1992-02-17
FR2340737B1 (xx) 1981-01-09
JPS6339568B2 (xx) 1988-08-05
DE2705105A1 (de) 1977-08-18
NL7701460A (nl) 1977-08-16

Similar Documents

Publication Publication Date Title
US4005196A (en) Vitaminized compositions for treating hypercholesterolemia
US4034083A (en) Compositions for inhibiting absorption of cholesterol
US4005195A (en) Compositions for treating hypercholesterolemia
US4241054A (en) Detoxifying lipophilic toxins
EP0023375B1 (en) Gall-stone dissolution compositions
US4849222A (en) Mixtures for treating hypercholesterolemia
US4950140A (en) Cookies containing psyllium
Holman et al. A case of human linolenic acid deficiency involving neurological abnormalities
DE69935995T2 (de) Polyungesättigen fettsäuren nährungsergänzung
EP0323666B1 (en) Mixed compositions for treating hypercholesterolemia
Kritchevsky Impact of red palm oil on human nutrition and health
US5116610A (en) Compositions for treating hypercholesterolemia
USRE33885E (en) Compositions for inhibiting absorption of cholesterol
USRE33996E (en) Compositions for treating hypercholesterolemia
US4962092A (en) Compositions for treating duodenal ulcers
GB1579241A (en) Compositions for treating hypercholes-terolemia
EP0415464A2 (en) Edible fat-containing products containing carotenoids
WO1992010941A1 (en) Edible fat-containing products containing vitamin e
WO2002049457A1 (en) The use of a non-absorbable, non-digestible lipid for the treatment of hyperbilirubinemia
IE60716B1 (en) Low calorie fat materials that eliminate laxative side effect

Legal Events

Date Code Title Description
PS Patent sealed
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
SP Amendment (slips) printed
PE20 Patent expired after termination of 20 years

Effective date: 19970210